Extracorporeal shock wave therapy in association with bromelain and escin for the management of patients affected by chronic prostatitis/chronic pelvic pain syndrome
Authors:
Open Access
- 25 November 2022
- journal article
- research article
- Published by Spandidos Publications in Biomedical Reports
- Vol. 18 (1) , 1-7
Abstract
Extracorporeal shock wave therapy (ESWT) has been purposed for the management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) with encouraging results. Phytotherapeutic compounds have been used in everyday clinical practice for patients with CP/CPSS due to their anti‑inflammatory properties. The present study aimed to investigate the effects of ESWT in association with the use of bromelain and escin extracts in patients with CP/CPSS. For this purpose, 95 patients with a clinical diagnosis of CP/CPSS were enrolled in the study. The patients were randomly allocated to either the ESWT plus bromelain and escin group (group A; n=48) or the ESWT only group (group B; n=47). A total of five weekly ESWT treatment sessions were administered alone or in combination with bromelain and escin. Each session consisted of 3,000 focused shock waves. Doses of 160 and 500 mg/day bromelain and escin were administered respectively for 5 weeks. The changes in urinary symptoms, pain and quality of life were considered the main outcome measures and were assessed at baseline, and at 4, 12 and 24 weeks of follow‑up. Urinary symptoms, pain and quality of life were evaluated using the international prostatic symptoms score (IPSS), visual analog scale (VAS) and the National Institutes of Health‑Chronic Prostatitis Symptom Index (NIH‑CPSI). After 4 weeks, the mean VAS score, mean IPSS and mean satisfaction rate score had significantly improved in patients receiving ESWT plus bromelain and escin. After 12 weeks, the mean IPSS and mean satisfaction rate score were stable in the ESWT plus bromelain and escin group, while the mean VAS score was significantly lower when compared with the baseline values in both groups. On the whole, the present study demonstrates that in patients affected by CP/CPPS, treatment with ESWT plus bromelain and escin leads to pain resolution, and both treatments improve the IPSS, VAS and NIH‑CPSI results.Keywords
This publication has 31 references indexed in Scilit:
- Pollen extract in association with vitamins provides early pain relief in patients affected by chronic prostatitis/chronic pelvic pain syndromeExperimental and Therapeutic Medicine, 2014
- Bromelain Treatment Leads to Maturation of Monocyte‐derived Dendritic Cells but Cannot Replace PGE2 in a Cocktail of IL‐1β, IL‐6, TNF‐α and PGE2Scandinavian Journal of Immunology, 2011
- Escin exerts synergistic anti-inflammatory effects with low doses of glucocorticoids in vivo and in vitroPhytomedicine, 2011
- New treatments for chronic prostatitis/chronic pelvic pain syndromeNature Reviews Urology, 2010
- Extracorporeal Shock Wave Therapy for the Treatment of Chronic Pelvic Pain Syndrome in Males: A Randomised, Double-Blind, Placebo-Controlled StudyEuropean Urology, 2009
- Mechanisms in Prostatitis/Chronic Pelvic Pain SyndromeJournal of Urology, 2008
- Muscle Tenderness in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: The Chronic Prostatitis Cohort StudyJournal of Urology, 2008
- INCIDENCE AND CLINICAL CHARACTERISTICS OF NATIONAL INSTITUTES OF HEALTH TYPE III PROSTATITIS IN THE COMMUNITYJournal of Urology, 2005
- The Italian Version of the National Institutes of Health Chronic Prostatitis Symptom IndexEuropean Urology, 2005
- THE DIAGNOSIS AND MANAGEMENT OF BACTERIAL PROSTATITISBritish Journal of Urology, 1972